Medi-Caps Limited (NSE:MEDICAPQ)
21.08
-0.79 (-3.61%)
At close: Nov 9, 2026
Medi-Caps Revenue
Medi-Caps had revenue of 58.40M INR in the quarter ending September 30, 2026, with 190.24% growth. This brings the company's total for the last twelve months to 145.64M, down -7.16% year-over-year. In the fiscal year ending March 31, 2026, Medi-Caps had annual revenue of 124.49M, down -51.14%.
Revenue (ttm)
145.64M
Revenue Growth
-7.16%
P/S Ratio
1.80
Revenue / Employee
16.18M
Employees
9
Market Cap
262.74M
Revenue by Segment
- Pharma Division 101.43M 81.5%
- Real Estate Division 23.06M 18.5%
Fiscal year ended Mar 31, 2026
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 124.49M | -130.29M | -51.14% |
| Mar 31, 2025 | 254.77M | -18.68M | -6.83% |
| Mar 31, 2024 | 273.45M | -220.26M | -44.61% |
| Mar 31, 2023 | 493.71M | -205.00M | -29.34% |
| Mar 31, 2022 | 698.71M | 111.52M | 18.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ambica Agarbathies Aroma & Industries | 1.42B |
| Biopol Chemicals | 946.78M |
| Sunil Healthcare | 840.63M |
| Saboo Sodium Chloro | 639.36M |
| C.J. Gelatine Products | 443.09M |
| Organic Coatings | 387.25M |
| Pressure Sensitive Systems (India) | 286.32M |
| Medi-Caps | 145.64M |